Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by اكتيبولاغيت استرا, جوندال مايكلfiledCriticalاكتيبولاغيت استرا
Priority to JO19931766ApriorityCriticalpatent/JO1766B1/en
Application grantedgrantedCritical
Publication of JO1766B1publicationCriticalpatent/JO1766B1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
The present invention relates to a novel class of biologically active compounds, to processes for their production and to their use in therapy. More particularly the invention provides immunogenic conjugates useful for generating T cell immunity against tumor-associated carbohydrate structures or against carbohydrate structures expressed on infectious agents and/or infected host cells. The said immunogenic conjugate comprises (i) a peptide component capable of binding an MHC class I molecule; and (ii) a carbohydrate component having the immunogenic specificity of said carbohydrate structure.
JO19931766A1993-10-201993-10-20New active compounds
JO1766B1
(en)
Strain of methylotrophic bacteria PSEUDOMONAS SP. VPKM N B-6798, ABLE TO USE FORMALDEHYDE AS THE ONLY SOURCE OF CARBON AND ENERGY IN A POOR MINERAL ENVIRONMENT